Wolfgang Lieb

Consolidated Researcher Details:

Institute:
Institute of Epidemiology, University of Kiel
Research Area:
Epidemiology and genetics of cardiometabolic diseases
Prof. Dr.
Wolfgang Lieb
wolfgang.lieb [at] epi.uni-kiel.de
+49 (0) 431 / 500- 30 201
Researcher ID: C-1990-2012

Why this profession?

Why this profession?

Wolfgang Lieb received his MD from Rostock University and his MSc in Epidemiology from Boston University. He is a board certified geneticist and epidemiologist.

After pursuing clinical training at the University Hospital in Regensburg (2001-2003), Wolfgang Lieb completed his Residency in Human Genetics at the University Hospital Schleswig-Holstein, Campus Lübeck (2003-2007). Parallel to his clinical training, he held a part-time postdoctoral research position at the Department of Cardiology in Lübeck and focused his research on the genetics of cardiovascular disease (CVD) and its risk factors.

From 2007-2010, he completed a Research Fellowship in Cardiovascular Epidemiology at the Framingham Heart Study and Boston University School of Medicine. During this period, Wolfgang Lieb broadened his research activities and worked e.g. on the determinants of cardiac and vascular remodeling, CVD as a life-course disease, and risk prediction models and the significance of novel biomarkers in the context of CVD.  

In 2010, he joined the Institute of Community Medicine at Greifswald University as Associate Professor (W2) and in 2012, he was appointed Director of the Institute of Epidemiology at the Christian Albrechts University in Kiel. In his current position, Wolfgang Lieb combines classic population-based epidemiological and genetic research in order to unravel the determinants of common inflammatory disease conditions, including CVD and related disorders.

Why RTG Genes, Environment and Inflammation?

Inflammatory disease conditions are determined by a complex interplay of genetic, molecular, environmental, and lifestyle factors. Analyses of the isolated and joint contributions of all of these factors will provide an improved understanding of the causes and determinants of inflammatory disease and potentially unravel new therapeutic targets.